GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » YIFAN PHARMACEUTICAL CO LTD (SZSE:002019) » Definitions » Shiller PE Ratio

YIFAN PHARMACEUTICAL CO (SZSE:002019) Shiller PE Ratio : 26.48 (As of May. 13, 2024)


View and export this data going back to 2004. Start your Free Trial

What is YIFAN PHARMACEUTICAL CO Shiller PE Ratio?

As of today (2024-05-13), YIFAN PHARMACEUTICAL CO's current share price is ¥13.77. YIFAN PHARMACEUTICAL CO's E10 for the quarter that ended in Mar. 2024 was ¥0.52. YIFAN PHARMACEUTICAL CO's Shiller PE Ratio for today is 26.48.

The historical rank and industry rank for YIFAN PHARMACEUTICAL CO's Shiller PE Ratio or its related term are showing as below:

SZSE:002019' s Shiller PE Ratio Range Over the Past 10 Years
Min: 17.63   Med: 61.03   Max: 415
Current: 26.48

During the past years, YIFAN PHARMACEUTICAL CO's highest Shiller PE Ratio was 415.00. The lowest was 17.63. And the median was 61.03.

SZSE:002019's Shiller PE Ratio is ranked worse than
53.01% of 532 companies
in the Drug Manufacturers industry
Industry Median: 25.645 vs SZSE:002019: 26.48

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

YIFAN PHARMACEUTICAL CO's adjusted earnings per share data for the three months ended in Mar. 2024 was ¥0.120. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥0.52 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


YIFAN PHARMACEUTICAL CO Shiller PE Ratio Historical Data

The historical data trend for YIFAN PHARMACEUTICAL CO's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YIFAN PHARMACEUTICAL CO Shiller PE Ratio Chart

YIFAN PHARMACEUTICAL CO Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 46.60 39.97 31.79 21.28 28.85

YIFAN PHARMACEUTICAL CO Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.21 25.18 23.61 28.85 21.50

Competitive Comparison of YIFAN PHARMACEUTICAL CO's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, YIFAN PHARMACEUTICAL CO's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


YIFAN PHARMACEUTICAL CO's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, YIFAN PHARMACEUTICAL CO's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where YIFAN PHARMACEUTICAL CO's Shiller PE Ratio falls into.



YIFAN PHARMACEUTICAL CO Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

YIFAN PHARMACEUTICAL CO's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=13.77/0.52
=26.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

YIFAN PHARMACEUTICAL CO's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, YIFAN PHARMACEUTICAL CO's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.12/114.6694*114.6694
=0.120

Current CPI (Mar. 2024) = 114.6694.

YIFAN PHARMACEUTICAL CO Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.076 98.200 0.089
201409 0.052 98.900 0.060
201412 0.115 99.000 0.133
201503 0.076 99.900 0.087
201506 0.084 99.500 0.097
201509 0.280 100.500 0.319
201512 0.061 100.600 0.070
201603 0.120 102.200 0.135
201606 0.210 101.400 0.237
201609 0.160 102.400 0.179
201612 0.150 102.600 0.168
201703 0.180 103.200 0.200
201706 0.260 103.100 0.289
201709 0.350 104.100 0.386
201712 0.360 104.500 0.395
201803 0.270 105.300 0.294
201806 0.180 104.900 0.197
201809 0.140 106.600 0.151
201812 0.020 106.500 0.022
201903 0.120 107.700 0.128
201906 0.280 107.700 0.298
201909 0.210 109.800 0.219
201912 0.130 111.200 0.134
202003 0.260 112.300 0.265
202006 0.310 110.400 0.322
202009 0.160 111.700 0.164
202012 0.060 111.500 0.062
202103 0.110 112.662 0.112
202106 0.060 111.769 0.062
202109 0.070 112.215 0.072
202112 -0.010 113.108 -0.010
202203 0.100 114.335 0.100
202206 0.030 114.558 0.030
202209 0.030 115.339 0.030
202212 -0.010 115.116 -0.010
202303 0.053 115.116 0.053
202306 0.037 114.558 0.037
202309 0.030 115.339 0.030
202312 -0.570 114.669 -0.570
202403 0.120 114.669 0.120

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


YIFAN PHARMACEUTICAL CO  (SZSE:002019) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


YIFAN PHARMACEUTICAL CO Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of YIFAN PHARMACEUTICAL CO's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


YIFAN PHARMACEUTICAL CO (SZSE:002019) Business Description

Traded in Other Exchanges
N/A
Address
No. 50 Qinshan, Jincheng, Lin'an Economic Development Zone, Hangzhou, Zhejiang, CHN, 311300
YIFAN PHARMACEUTICAL CO LTD is a China-based company engaged in pharmaceutical innovation and manufacturing. The company focuses its activities on key areas like macromolecular biologics, high-value pharmaceuticals, and differentiated traditional Chinese medicines. The products of the company are F-627 for Neutropenia and Parkinson's disease, F-652 for acute alcoholic hepatitis, GvHD and acute pancreatitis and F-899 for growth deficiency. The company's products are sold in China and internationally.

YIFAN PHARMACEUTICAL CO (SZSE:002019) Headlines

No Headlines